IONS

IonisA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

25%

Probability

Target price

$95.00

Analysis reference price unavailable

Analysis 2026-08-04 · RankAlpha Sentiment Codex

Most likely

Base case

50%

Probability

Target price

$68.00

Analysis reference price unavailable

Analysis 2026-08-04 · RankAlpha Sentiment Codex

B-

Bear case

25%

Probability

Target price

$42.00

Analysis reference price unavailable

Analysis 2026-08-04 · RankAlpha Sentiment Codex

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-08-04

AI commentary

News tone is moderately positive after the Q2 report, with reported earnings and revenue above stored consensus context and guidance reaffirmed. Social, options, short-interest, employee, and analyst-revision data are unavailable or insufficient in the packet, so confidence remains below that of a fully triangulated bullish thesis.

RankAlpha Sentiment Codex - 2026-08-04

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-07-29eventQ2 beat with reaffirmed 2026 outlookMedium impact

Q2 revenue was $268 million, and Ionis said it remained on track for 2026 financial guidance; stored earnings context reports adjusted EPS of -$0.43 versus a -$0.89 consensus estimate. [#SEC-8K-2026-07-29] [#PR-EARNINGS-2026-07-30]

2027-08-04catalystTryngolza sHTG commercial rampHigh impact

Ionis reported early launch momentum following the broader sHTG approval, with strong underlying FCS demand and expectations for acceleration in the second half of 2026. [#SEC-8K-2026-07-29]

2027-08-04catalystZilganersen regulatory decisionHigh impact

Management expects approval of zilganersen for Alexander disease in the second half of 2026, potentially positioning Ionis for its first independent neurology launch. [#SEC-8K-2026-07-29]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-08-04 • Updated nightlySource: Internal modelMethodology